Authors' Reply
Comment on: https://www.jmir.org/2025/1/e71845/
doi:10.2196/73174
Keywords
Thank you for your reading of our article “A 4-Week Mobile App–Based Telerehabilitation Program vs Conventional In-Person Rehabilitation in Older Adults With Sarcopenia: Randomized Controlled Trial” [
]. We are truly gratified that our study has garnered your attention and interest and has sparked meaningful discussion. In response to the points raised by the authors [ ], our answers are as follows.Regarding the first point, first, we had already fully considered that the older adult population might have difficulties in understanding movements accurately and that there could be differences in individual comprehension if they only watched videos and read the text. Therefore, before formally using the app for training, the telerehabilitation group attended an in-person session, where a physical therapist guided the participants through a simulation of the movements and provided detailed instructions on how to use the app. This was done to ensure that participants could follow our intended exercise protocols as closely as possible during home-based training and to minimize individual differences in understanding. These details are thoroughly described in the study methods. Second, the average age of the participants in the telerehabilitation group was 70.47 years. For feasibility, the study included patients who had basic literacy skills and were able to operate smartphones. We believe the study results are applicable to the population defined by the inclusion and exclusion criteria, but we do not claim that they can be generalized to all older adults with sarcopenia. How to support older adults with sarcopenia who cannot use app-based resources is an area worthy of further investigation. We agree that integrating motion-tracking technology into the study protocol to provide real-time remote corrections and guidance during telerehabilitation would be an ideal approach [
], which could be a direction for future improvement.Regarding the second point, we agree that the effectiveness of telerehabilitation is related to the chosen setting. Results obtained in a specific hospital environment are suitable for generalization to similar contexts. How to assist older patients in areas with limited technological infrastructure is an important area for further research. Before the study, we had thoroughly considered the potential impact of comorbidities and medications on the study outcomes. We excluded patients with other neuromuscular diseases, those with severe skeletal disorders, or those using corticosteroids, which might confound the interpretation of the results.
Regarding the third point, muscle function is indeed influenced by a wide range of factors [
]. In addition to exercise, which is the most important factor discussed in this study, nutrition, sleep, and daily activity levels also play significant roles. It would be ideal to include all these factors in a single study. However, monitoring any of these indicators in the older adult population would add another layer of complexity to the research. We agree that mental health and social functioning should also be considered as end points [ ], which may be further explored in future studies.We truly appreciate the authors’ letter, which has prompted deeper reflection on our study and provided inspiration for future research directions.
Conflicts of Interest
None declared.
References
- Zhang L, Ge Y, Zhao W, Shu X, Kang L, Wang Q, et al. A 4-week mobile app-based telerehabilitation program vs conventional in-person rehabilitation in older adults with sarcopenia: randomized controlled trial. J Med Internet Res. Jan 24, 2025;27:e67846. [FREE Full text] [CrossRef] [Medline]
- Zhang H, Liu X. Balancing challenges and opportunities when evaluating remote rehabilitation for sarcopenia in older adults. J Med Internet Res. 2025;27:e71845. [CrossRef]
- Yuan W, Shi W, Chen L, Liu D, Lin Y, Li Q, et al. Digital physiotherapeutic scoliosis-specific exercises for adolescent idiopathic scoliosis: a randomized clinical trial. JAMA Netw Open. Feb 03, 2025;8(2):e2459929. [FREE Full text] [CrossRef] [Medline]
- Janssen TA, Lowisz CV, Phillips S. From molecular to physical function: the aging trajectory. Curr Res Physiol. 2025;8:100138. [FREE Full text] [CrossRef] [Medline]
- Ge H, Yang S, Su W, Guan W, Dong S, Chang W, et al. The relationship between sarcopenia and mental health status in Chinese older adults: the mediating role of activities of daily living. BMC Geriatr. Jan 29, 2025;25(1):64. [FREE Full text] [CrossRef] [Medline]
Edited by T Leung; This is a non–peer-reviewed article. submitted 26.02.25; accepted 13.03.25; published 01.04.25.
Copyright©Lu Zhang, Ying Ge, Wowa Zhao, Xuan Shu, Lin Kang, Qiumei Wang, Ying Liu. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 01.04.2025.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research (ISSN 1438-8871), is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.